BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 7556288)

  • 1. Ascitic fluid-associated lymphocytes in patients with metastatic ovarian cancer. Analysis of lymphocyte subsets and of phenotypical changes induced by "in vitro".
    Loiudice L; Dell'Osso A; Loria MP; D'Ambra PP; Lasaracina E; Crollo E; Lucivero G
    Eur J Gynaecol Oncol; 1995; 16(4):301-6. PubMed ID: 7556288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenotypic and functional analysis of tumor-infiltrating lymphocytes compared with tumor-associated lymphocytes from ascitic fluid and peripheral blood lymphocytes in patients with advanced ovarian cancer.
    Santin AD; Hermonat PL; Ravaggi A; Bellone S; Roman JJ; Smith CV; Pecorelli S; Radominska-Pandya A; Cannon MJ; Parham GP
    Gynecol Obstet Invest; 2001; 51(4):254-61. PubMed ID: 11408737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T lymphocytes and cytokine production in ascitic fluid of ovarian malignancies.
    Chen CK; Wu MY; Chao KH; Ho HN; Sheu BC; Huang SC
    J Formos Med Assoc; 1999 Jan; 98(1):24-30. PubMed ID: 10063270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of blood transfusion during radiotherapy on the immune function of patients with cancer of the uterine cervix: role of interleukin-10.
    Santin AD; Bellone S; Palmieri M; Bossini B; Dunn D; Roman JJ; Pecorelli S; Cannon M; Parham GP
    Int J Radiat Oncol Biol Phys; 2002 Dec; 54(5):1345-55. PubMed ID: 12459356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The phenotype of ascitic fluid lymphocytes in patients with ovarian carcinoma and other primaries.
    Melichar B; Tousková M; Tosner J; Kopecký O
    Onkologie; 2001 Apr; 24(2):156-60. PubMed ID: 11441296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of lymphocyte subsets in ascitic fluid and peripheral blood of decompensated cirrhotic patients with chronic hepatitis C and alcoholic liver disease: A pivotal study.
    Romanelli RG; Vitiello G; Gitto S; Giudizi MG; Biagiotti R; Carraresi A; Vizzutti F; Laffi G; Almerigogna F
    Int J Immunopathol Pharmacol; 2020; 34():2058738420929587. PubMed ID: 32524881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and biological effects of intraperitoneal injections of recombinant interferon-gamma and recombinant interleukin 2 with or without tumor-infiltrating lymphocytes in patients with ovarian or peritoneal carcinoma.
    Freedman RS; Kudelka AP; Kavanagh JJ; Verschraegen C; Edwards CL; Nash M; Levy L; Atkinson EN; Zhang HZ; Melichar B; Patenia R; Templin S; Scott W; Platsoucas CD
    Clin Cancer Res; 2000 Jun; 6(6):2268-78. PubMed ID: 10873077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Lymphocyte activation markers in patients with ovarian cancer].
    Nowicka A; Rogala E; Bednarek W; Barczyński B; Wertel I; Piekarczyk W; Kotarski J
    Ginekol Pol; 2012 Oct; 83(10):737-43. PubMed ID: 23383558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Leukocyte and lymphocyte populations in peripheral blood and malignant ascites in patients with ovarian carcinoma].
    Radke J; Schmidt D; Böhme M; Morenz J; Weise W
    Geburtshilfe Frauenheilkd; 1994 Dec; 54(12):675-8. PubMed ID: 7531661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Evaluation of the intracellular expression of interleukin 17 in patients with ovarian cancer].
    Rogala E; Nowicka A; Bednarek W; Barczyński B; Wertel I; Zakrzewski M; Kotarski J
    Ginekol Pol; 2012 Jun; 83(6):424-8. PubMed ID: 22880461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different concentrations of interleukins in the peritoneal fluid of women with endometriosis: relationships with lymphocyte subsets.
    Gallinelli A; Chiossi G; Giannella L; Marsella T; Genazzani AD; Volpe A
    Gynecol Endocrinol; 2004 Mar; 18(3):144-51. PubMed ID: 15255283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Without prior stimulation, tumor-associated lymphocytes from malignant effusions lyse autologous tumor cells in the presence of bispecific antibody HEA125xOKT3.
    Strauss G; Gückel B; Wallwiener D; Moldenhauer G
    Clin Cancer Res; 1999 Jan; 5(1):171-80. PubMed ID: 9918216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peritoneal natural killer cells from epithelial ovarian cancer patients show an altered phenotype and bind to the tumour marker MUC16 (CA125).
    Belisle JA; Gubbels JA; Raphael CA; Migneault M; Rancourt C; Connor JP; Patankar MS
    Immunology; 2007 Nov; 122(3):418-29. PubMed ID: 17617155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of an IL-10-producing HLA-DR-negative monocyte subset in the malignant ascites of patients with ovarian carcinoma that inhibits cytokine protein expression and proliferation of autologous T cells.
    Loercher AE; Nash MA; Kavanagh JJ; Platsoucas CD; Freedman RS
    J Immunol; 1999 Dec; 163(11):6251-60. PubMed ID: 10570318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor-infiltrating lymphocytes contain higher numbers of type 1 cytokine expressors and DR+ T cells compared with lymphocytes from tumor draining lymph nodes and peripheral blood in patients with cancer of the uterine cervix.
    Santin AD; Ravaggi A; Bellone S; Pecorelli S; Cannon M; Parham GP; Hermonat PL
    Gynecol Oncol; 2001 Jun; 81(3):424-32. PubMed ID: 11371133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of costimulatory molecules CD80 and CD86 and their receptors CD28, CTLA-4 on malignant ascites CD3+ tumour-infiltrating lymphocytes (TIL) from patients with ovarian and other types of peritoneal carcinomatosis.
    Melichar B; Nash MA; Lenzi R; Platsoucas CD; Freedman RS
    Clin Exp Immunol; 2000 Jan; 119(1):19-27. PubMed ID: 10606960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of unique clusters of T, dendritic, and innate lymphoid cells in the peritoneal fluid of ovarian cancer patients.
    Vazquez J; Chavarria M; Lopez GE; Felder MA; Kapur A; Romo Chavez A; Karst N; Barroilhet L; Patankar MS; Stanic AK
    Am J Reprod Immunol; 2020 Sep; 84(3):e13284. PubMed ID: 32524661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significant differences of lymphocytes isolated from ascites of patients with ovarian cancer compared to blood and tumor lymphocytes. Association of CD3+CD56+ cells with platinum resistance.
    Bamias A; Tsiatas ML; Kafantari E; Liakou C; Rodolakis A; Voulgaris Z; Vlahos G; Papageorgiou T; Tsitsilonis O; Bamia C; Papatheodoridis G; Politi E; Archimandritis A; Antsaklis A; Dimopoulos MA
    Gynecol Oncol; 2007 Jul; 106(1):75-81. PubMed ID: 17433425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytokine production by helper T cell populations from the synovial fluid and blood in patients with rheumatoid arthritis.
    al-Janadi M; al-Balla S; al-Dalaan A; Raziuddin S
    J Rheumatol; 1993 Oct; 20(10):1647-53. PubMed ID: 8295173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-12-mediated tumoricidal activity of patient lymphocytes in an autologous in vitro ovarian cancer assay system.
    DeCesare SL; Michelini-Norris B; Blanchard DK; Barton DP; Cavanagh D; Roberts WS; Fiorica JV; Hoffman MS; Djeu JY
    Gynecol Oncol; 1995 Apr; 57(1):86-95. PubMed ID: 7705706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.